In a large study of 2229 subjects at increased risk for type 2 diabetes the impact of common SLC5A2 variants (rs9934336, rs9924771, rs3813008 and rs3116150) on empagliflozin response was analyzed. Here, SLC5A2 is linked to type 2 diabetes mellitus.